BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25408720)

  • 1. Apoptosis in colorectal cancer.
    Stoian M; State N; Stoica V; Radulian G
    J Med Life; 2014 Jun; 7(2):160-4. PubMed ID: 25408720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and predisposition to oral cancer.
    Polverini PJ; Nör JE
    Crit Rev Oral Biol Med; 1999; 10(2):139-52. PubMed ID: 10759418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterodimerization of Bcl-2 and Bcl-X(L) with Bax and Bad in colorectal cancer.
    Hattori T; Ookawa N; Fujita R; Fukuchi K
    Acta Oncol; 2000; 39(4):495-500. PubMed ID: 11041112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria and apoptosis.
    Mignotte B; Vayssiere JL
    Eur J Biochem; 1998 Feb; 252(1):1-15. PubMed ID: 9523706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells.
    Liu L; Chen L; Xu Y; Li R; Du X
    Biochem Biophys Res Commun; 2010 Sep; 400(2):236-40. PubMed ID: 20727858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression.
    Kim KM; Song JJ; An JY; Kwon YT; Lee YJ
    J Biol Chem; 2005 Dec; 280(49):41047-56. PubMed ID: 16199534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL-2: the pendulum of the cell fate.
    Blandino G; Strano S
    J Exp Clin Cancer Res; 1997 Mar; 16(1):3-10. PubMed ID: 9148853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
    Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
    Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape.
    Huber V; Fais S; Iero M; Lugini L; Canese P; Squarcina P; Zaccheddu A; Colone M; Arancia G; Gentile M; Seregni E; Valenti R; Ballabio G; Belli F; Leo E; Parmiani G; Rivoltini L
    Gastroenterology; 2005 Jun; 128(7):1796-804. PubMed ID: 15940614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia and defective apoptosis drive genomic instability and tumorigenesis.
    Nelson DA; Tan TT; Rabson AB; Anderson D; Degenhardt K; White E
    Genes Dev; 2004 Sep; 18(17):2095-107. PubMed ID: 15314031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bcl-2-regulated apoptotic pathway.
    Willis S; Day CL; Hinds MG; Huang DC
    J Cell Sci; 2003 Oct; 116(Pt 20):4053-6. PubMed ID: 12972498
    [No Abstract]   [Full Text] [Related]  

  • 12. Apoptosis: molecular regulation of cell death.
    Hale AJ; Smith CA; Sutherland LC; Stoneman VE; Longthorne VL; Culhane AC; Williams GT
    Eur J Biochem; 1996 Feb; 236(1):1-26. PubMed ID: 8617251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of antiapoptotic genes in human endometrial carcinoma: bcl-XL succeeds bcl-2 function in neoplastic cells.
    Crescenzi E; Criniti V; Pianese M; Tecce MF; Palumbo G
    Gynecol Oncol; 2000 Jun; 77(3):419-28. PubMed ID: 10831353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of apoptosis during development of colorectal cancer.
    Bedi A; Pasricha PJ; Akhtar AJ; Barber JP; Bedi GC; Giardiello FM; Zehnbauer BA; Hamilton SR; Jones RJ
    Cancer Res; 1995 May; 55(9):1811-6. PubMed ID: 7728743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in colorectal cancer and its relationship to bcl-2 expression.
    Iida A; Yamaguchi A; Hirose K
    J Surg Oncol; 2000 Apr; 73(4):219-23. PubMed ID: 10797335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escape from negative regulation of growth by transforming growth factor beta and from the induction of apoptosis by the dietary agent sodium butyrate may be important in colorectal carcinogenesis.
    Hague A; Manning AM; van der Stappen JW; Paraskeva C
    Cancer Metastasis Rev; 1993 Sep; 12(3-4):227-37. PubMed ID: 8281610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).
    Ravi R; Bedi A
    Cancer Res; 2002 Mar; 62(6):1583-7. PubMed ID: 11912124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in tumorigenesis and cancer therapy.
    McGill G; Fisher DE
    Front Biosci; 1997 Jul; 2():d353-79. PubMed ID: 9230063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L; Fang B
    Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxyphilic and non-oxyphilic thyroid carcinoma cell lines differ in expressing apoptosis-related genes.
    Allìa E; Cassoni P; Marrocco T; Volante M; Bussolati B; Wong M; Clark OH; Papotti M
    J Endocrinol Invest; 2003 Jul; 26(7):660-7. PubMed ID: 14594119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.